Table 3.
Inflammatory markers in patients during ICU stay.
| No. / total No. (%)a | p value | |||
|---|---|---|---|---|
|
| ||||
| Total N=118 | Treatment group N=33 | Control group N=85 | ||
| White blood cell count, × 109/L | ||||
| <3.5 | 11(9.2) | 3(9.0) | 8(9.4) | >0.999 |
| >9.5 | 79(66.8) | 14(42.4) | 65(76.4) | 0.0009 |
| Lymphocyte count, × 109/L | ||||
| <1.1 | 98(83.0) | 20(60.6) | 78(91.7) | 0.0002 |
| >3.2 | 1(0.8) | 0(0) | 1(1.1) | >0.999 |
| Procalcitonin, ng/ml | ||||
| increased | 53(44.8) | 14(42.4) | 39(45.8) | 0.837 |
| C-reactive protein, mg/l | ||||
| increased | 96(81.3) | 21(63.6) | 75(88.2) | 0.003 |
| TNF-a, pg/ml | ||||
| increased | 67/93(71.9) | 22/26(84.6) | 45/67(67.1) | 0.123 |
| IL-6, pg/ml | ||||
| increased | 87/94(92.5) | 19/26(73.0) | 65/68(95.6) | 0.004 |
| IL-10, pg/ml | ||||
| increased | 59/82(72.8) | 14/26(53.8) | 45/66(80.3) | 0.018 |
Abbreviations: ICU, intensive care unit.
aFor some variables, not available for all patients.
Boldface values were considered statistically significant.